FDA unearths a minefield of quality issues at the contractor manufacturing Moderna's jabs
That’s a product recall if ever there was one...
The Achilles' heel of mRNA jabs
The Achilles' heel of these mRNA jabs has always been the manufacturing and distribution supply chain. Most people don’t realise it, because they have been conditioned to believe drugs are found by accident, not developed and produced like other consumer products.
In developing and manufacturing the jabs 10x faster than ever before, multiple c$ck-ups were going to occur. This is the latest we know about, because US FDA has gone in and done the inspection:
Moderna's new booster launch tripped up by production issues at Catalent plant, by Kevin Dunleavy, FiercePharma, Sep 21, 2022 11:23am.
At last, we are seeing the dreaded and much feared (pre-pandemic) FDA 483 Form being issued. This is it below, taken from the article:
FDA 483 Form Catalent Bloomingdale
It contains substantial findings that could leave a person wondering if that plant can go on operating without major corrective actions—that would take months if not a year or two, as these are deep rooted i…